Xconomy National

Archives

by in

Entry	Author	Date	Location
Light Sciences Oncology Stumbles in Clinical Trial, Layoffs Loom	Luke Timmerman	10/04/11	Seattle
Delcath Takes FDA Hassle in Stride, Prepares to Sell New Chemo Device Overseas	Arlene Weintraub	08/17/11	New York
Polaris Prepares for Liver Cancer Trial, Goal Draws Near for Hepatitis C Drug, & More San Diego Life Sciences News	Bruce V. Bigelow	04/28/11	San Diego
Tekmira-Alnylam Lawsuit Centers on Drug Carrier Particles	Ryan McBride	03/18/11	Boston
Jennerex, Maker of Cancer-Fighting Virus, Says Early Data Shows Survival Benefit	Luke Timmerman	02/17/11	San Francisco
Alnylam CEO John Maraganore On Corporate Near-Termism, and Restoring Faith in RNAi	Luke Timmerman	12/06/10	Boston
Alnylam Seeks to Prove RNAi Skeptics Wrong After Layoffs, End of Novartis Deal	Ryan McBride	10/21/10	Boston
Jennerex, Charging Ahead With Tumor-Killing Virus, Follows Biotech Road Less Traveled	Luke Timmerman	09/09/10	San Francisco
Light Sciences Oncology Sits Tight, Awaits Key Cancer Trial Results This Summer	Luke Timmerman	03/01/10	Seattle
Merck’s Alan Sachs, on RNAi’s Big Challenge: Delivery, Delivery, Delivery	Luke Timmerman	01/21/10	National
Alnylam, Studying History of Genzyme, Eyes Drug to Make Big Impact for Rare Disease	Luke Timmerman	12/14/09	Boston
Light Sciences Oncology Lines Up Extra $35M Financing For Targeted Cancer Treatment	Luke Timmerman	11/05/09	Seattle
Brown U. and Johns Hopkins Researchers Form Sentient Bioscience to Improve Liver Cancer Treatment	Ryan McBride	09/15/09	Boston
Light Sciences Starts BPH Trial	Luke Timmerman	08/18/09	Seattle
Light Sciences Oncology, Led by CEO on the Go, Prepares for Its Big Day	Luke Timmerman	07/24/08	Seattle
Light Sciences Oncology Raises $40 Million for Cancer Trials	Luke Timmerman	07/15/08	Seattle
Page 1 of 1